F.D.A. Expands Access to Clozapine, a Key Treatment for Schizophrenia

Federal regulators will no longer require patients to provide blood tests before receiving the drug from pharmacies.Federal regulators will no longer require patients to provide blood tests before receiving the drug from pharmacies. Read More

Leave a Comment

Your email address will not be published. Required fields are marked *